tiprankstipranks
Trending News
More News >
VitaSpring Biomedical (VSBC)
OTHER OTC:VSBC
US Market

VitaSpring Biomedical (VSBC) Financial Statements

Compare
3 Followers

VitaSpring Biomedical Financial Overview

VitaSpring Biomedical's market cap is currently $2.30M. The company's EPS TTM is $; its P/E ratio is ―; VitaSpring Biomedical is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jan 23Jan 22Jan 21Jan 20Jan 19
Income Statement
Total Revenue$ 0.00$ 5.61M$ 248.20K$ 15.14K$ 17.18K
Gross Profit$ -219.34K$ 2.07M$ 112.20K$ 1.70K$ 13.27K
Operating Income$ -4.18M$ 1.48M$ -425.38K$ -19.49K$ -21.33K
EBITDA$ -3.95M$ 1.49M$ -424.26K$ -19.04K$ -21.95K
Net Income$ -4.16M$ 1.26M$ -425.38K$ 6.92K$ -22.40K
Balance Sheet
Cash & Short-Term Investments$ 29.66K$ 107.21K$ 45.40K$ 0.00$ 105.00
Total Assets$ 765.95K$ 3.60M$ 189.40K$ 0.00$ 11.43K
Total Debt$ 262.98K$ 463.57K$ 0.00$ 0.00$ 18.35K
Net Debt$ 233.32K$ 356.36K$ -45.40K$ 0.00$ 18.25K
Total Liabilities$ 3.16M$ 2.03M$ 93.03K$ 0.00$ 18.35K
Stockholders' Equity$ -2.40M$ 1.58M$ 386.77K$ -18.26K$ -6.92K
Cash Flow
Free Cash Flow$ -77.56K$ 11.81K$ -42.13K$ -105.00$ -34.25K
Operating Cash Flow$ -77.56K$ 84.81K$ -42.13K$ -105.00$ -34.25K
Investing Cash Flow$ 0.00$ -73.00K$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 0.00$ 50.00K$ 87.53K$ 0.00$ 29.15K
Currency in USD

VitaSpring Biomedical Earnings and Revenue History

VitaSpring Biomedical Debt to Assets

VitaSpring Biomedical Cash Flow

VitaSpring Biomedical Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.